Observational studyThe oncologist2022

Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer.

Satoshi Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.